Pharmicell Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmicell Company Limited with three other
companies in this sector in South Korea:
WooGene B&G CO., LTD
sales of 23.51 billion Korean Won [US$19.79 million]
CMG Pharmaceutical Co Ltd
(27.04 billion Korean Won [US$22.77 million]
of which 100%
was Pharmaceutial Manufacture), and
Daesung Microbiological Labs. Co., Limited
(31.03 billion Korean Won [US$26.12 million]
During the year ended December of 2015, sales at
Pharmicell Company Limited were 25.18 billion Korean Won (US$21.20 million).
increase of 24.9%
versus 2014, when the company's sales were 20.16 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Pharmicell Company Limited
reported sales of 33.41 billion Korean Won.
Sales of Chemical saw an increase
35.9% in 2015, from
16.33 billion Korean Won to 22.20 billion Korean Won.
Not all segments of Pharmicell Company Limited experienced an increase in sales in 2015:
sales of Bio-Business fell 22.0% to 2.98 billion Korean Won.